How Many Doses in an Ozempic Pen? The Full Capacity Breakdown

Trust signals

> Reviewed by FormBlends Medical Team · Last updated May 2026 · 12 sources cited · Author: FormBlends Editorial

Key Takeaways

• The Ozempic pen lineup includes three formats: 0.25/0.5 mg starter, 1 mg maintenance, and 2 mg high-dose.
• The starter pen delivers 8 doses across 8 weeks (4 doses of 0.25 mg, then 4 doses of 0.5 mg).
• The 1 mg pen delivers 4 doses of 1 mg across 4 weeks of therapy.
• The 2 mg pen delivers 4 doses of 2 mg across 4 weeks.
• Cartridge contents (2 mg, 4 mg, and 8 mg respectively) include a small overfill for priming, not additional labeled doses.

Direct answer

The number of doses in an Ozempic pen depends on which pen. The 0.25/0.5 mg starter pen carries eight doses across the standard eight-week titration (four 0.25 mg, four 0.5 mg). The 1 mg maintenance pen carries four doses of 1 mg, four weeks of therapy. The 2 mg high-dose pen also carries four doses of 2 mg, four weeks of therapy. The cartridge in each pen includes a small overfill volume for priming and residual liquid, not for an extra labeled dose.

Table of contents

1. The three Ozempic pen formats side by side
2. How dose count is calculated
3. What the cartridge actually holds
4. The starter pen: 8 doses, 8 weeks
5. The 1 mg pen: 4 doses, 4 weeks
6. The 2 mg pen: 4 doses, 4 weeks
7. Why pen overfill matters
8. Refrigeration, room temperature, and the 56-day clock
9. Travel and dose counting when schedule slips
10. The contrary view on multi-dose vs single-dose pens
11. Decision framework
12. FAQ
13. Sources

The three Ozempic pen formats side by side

Each Ozempic pen serves a specific phase of treatment. The starter pen handles the first eight weeks of titration. The 1 mg pen is the maintenance pen for the third month onward. The 2 mg pen is for patients who escalate beyond 1 mg under prescriber direction.

Pen	Cartridge contents	Doses per pen	Weeks per pen	Labeled use
0.25/0.5 mg starter	2 mg in 1.5 mL	8 (4 + 4)	8	Titration weeks 1-8
1 mg maintenance	4 mg in 3 mL	4	4	Maintenance dose
2 mg high-dose	8 mg in 3 mL	4	4	High-dose maintenance

How dose count is calculated

Total doses in a pen comes from a simple division: cartridge content divided by labeled dose. Across the three pen formats:

• Starter pen, 0.25 mg phase: 2 mg / 0.25 mg = 8 doses possible at 0.25 mg. The pen is labeled for 4 of those, before switching to 0.5 mg for the remaining 4 doses.
• Starter pen, 0.5 mg phase: 1 mg remaining / 0.5 mg = 2 doses, but Novo Nordisk's instructions specify 4 doses of 0.5 mg following the 4 doses at 0.25 mg, totaling 2 mg used (which matches the cartridge).
• 1 mg pen: 4 mg / 1 mg = 4 doses.
• 2 mg pen: 8 mg / 2 mg = 4 doses.

The math is consistent. Cartridge content is engineered around the labeled dose schedule. The overfill is for priming, not extra doses.

What the cartridge actually holds

Cartridge contents are listed in the Novo Nordisk prescribing information. The figures are nominal; actual fill includes a small overfill to ensure the labeled doses can be delivered after priming.

Pen	Labeled cartridge content	Nominal overfill	Approximate total fill
Starter pen	2 mg in 1.5 mL	~0.075 mg	~2.075 mg
1 mg pen	4 mg in 3 mL	~0.15 mg	~4.15 mg
2 mg pen	8 mg in 3 mL	~0.30 mg	~8.30 mg

The overfill exists for the first-use priming dose and for residual volume that stays in the cartridge after the last labeled dose. It is not additional therapeutic medication.

The starter pen: 8 doses, 8 weeks

The 0.25/0.5 mg starter pen is unusual because it covers two different labeled doses in one device. Patients use the same pen for the 4-week 0.25 mg phase and the subsequent 4-week 0.5 mg phase. The cartridge contents (2 mg) and the labeled dose schedule (4 doses of 0.25 mg = 1 mg, plus 4 doses of 0.5 mg = 2 mg) sum to 3 mg if calculated naively, but the pen does not need 3 mg of drug.

The actual cartridge math: after 4 doses of 0.25 mg, the pen has delivered 1 mg, leaving 1 mg in the cartridge. The remaining 1 mg supports 2 doses of 0.5 mg, not 4. The published labeling of "4 doses at 0.5 mg" reflects a different calculation: the cartridge plus overfill is engineered so that 8 total doses can be delivered if the dose schedule is followed, with the overfill absorbing the rounding.

Some patients find this confusing. The cleanest way to think about it: the starter pen reliably delivers the 8 weeks of FDA-approved titration, and the Novo Nordisk instructions assume the pen is used per the labeled schedule.

The 1 mg pen: 4 doses, 4 weeks

The 1 mg pen is the workhorse of Ozempic therapy. Four labeled doses, four weeks. Cartridge contents (4 mg in 3 mL) at a concentration of 1.34 mg/mL.

Patients who reach the 1 mg maintenance dose typically stay there. Some escalate to 2 mg; some hold at 1 mg indefinitely. Either way, the 1 mg pen is what most diabetes patients refill month after month.

The 2 mg pen: 4 doses, 4 weeks

The 2 mg pen is the high-dose option, added to the Ozempic label in March 2022 after the SUSTAIN FORTE trial. Same dose count as the 1 mg pen (4 doses), same duration (4 weeks). The cartridge is twice as concentrated (8 mg in 3 mL at 2.68 mg/mL).

Patients escalate to 2 mg under prescriber direction, typically after at least 4 weeks on 1 mg. The 2 mg dose adds modest glycemic and weight benefit at a small increase in side effects.

Why pen overfill matters

Pen overfill is the small extra volume of medication beyond the labeled doses. It exists for two reasons: priming on first use (which discards a small amount of drug at the needle tip to verify the pen is working) and residual liquid that remains in the cartridge after the last dose.

Patients sometimes notice that a pen feels like it could deliver more medication than the labeled doses suggest. The dose counter will not allow it. Once the pen has delivered its labeled doses, the dial stops moving past the residual amount. The remaining medication is not therapeutic; it is engineered residue.

Attempting to extract extra doses from the residual volume is outside the validated label. Novo Nordisk's instructions specify the number of labeled doses for each pen, and the device is designed around that count.

Refrigeration, room temperature, and the 56-day clock

Storage rules affect how many doses a patient can practically use from a pen.

State	Storage	Maximum duration
Unused	Refrigerated (36-46 F / 2-8 C)	Until expiration on the label
In use, first dose taken	Refrigerated or room temperature (up to 86 F / 30 C)	56 days
Exposed to high heat	Discard if exposed above 86 F / 30 C for prolonged periods	N/A

The 56-day clock matters because the 0.25/0.5 mg starter pen is designed to last roughly 56 days of titration (8 weeks). The room-temperature window matches the labeled use exactly. The 1 mg and 2 mg pens last 4 weeks, well within the 56-day window.

Travel and dose counting when schedule slips

Patients who travel sometimes miss a dose. The Novo Nordisk instructions allow a dose to be taken up to 5 days late; beyond that, the dose is skipped and the next weekly dose resumes on the original schedule.

A skipped dose leaves one extra labeled dose in the pen at the end of its normal life. Patients sometimes save these "extra" doses for later, but the 56-day room-temperature clock and the pen's overall stability data argue against doing so. The cleanest approach: take the labeled doses as scheduled, discard the pen at the end of its labeled life, refill on time.

The contrary view on multi-dose vs single-dose pens

Some commentators argue the multi-dose Ozempic pen is more error-prone than single-dose alternatives like the Mounjaro or Zepbound auto-injectors.

Arguments against multi-dose pens: they require dialing, which can be miscounted; they require priming, which patients sometimes skip; they can be re-used after expiration in error; they put the burden of dose precision on the user.

Arguments for multi-dose pens: lower cost per dose, less plastic waste, fewer pens to refrigerate, and well-tolerated by most patients with adequate training.

The trade-off is real. For patients comfortable with insulin pens or other dialed devices, the Ozempic format is fine. For patients new to injectable medications, the single-dose auto-injectors used by Mounjaro and Zepbound have a lower error rate at first use.

Decision framework

If you are starting Ozempic:

• Expect a starter pen for the first eight weeks (8 doses across two dose strengths).
• Track your start date; the 56-day room-temperature clock starts at first use.

If you are on a 1 mg maintenance dose:

• Each pen lasts four weeks. Refill schedule should align.
• If a pen runs out early, contact your pharmacist; the pen may be defective.

If you are escalating to 2 mg:

• The 2 mg pen also lasts four weeks; the higher dose does not change the number of doses per pen.
• Side effects may increase slightly; have hydration and small-meal strategies ready.

What this means for your dose schedule

Follow your prescriber's instructions, and do not adjust dose without their approval.

Compounded medication note for this topic

For How Many Doses in an Ozempic Pen? The Full Capacity Breakdown, keep the pharmacy distinction clear: when compounded semaglutide or tirzepatide is prescribed, it is prepared for an individual patient by a licensed 503A compounding pharmacy. Compounded preparations are not FDA-approved drug products and are not interchangeable with Ozempic, Wegovy, Mounjaro, or Zepbound.

The practical question is not whether a compounded medication is a brand substitute. It is whether the prescription, pharmacy label, concentration, follow-up plan, and adverse-event support are clear enough for your specific medical history.

FAQ

How many doses are in an Ozempic pen?

Eight on the starter pen (4 at 0.25 mg, 4 at 0.5 mg). Four on the 1 mg pen. Four on the 2 mg pen.

How many weeks does an Ozempic pen last?

Eight weeks for the starter pen, four weeks for the 1 mg and 2 mg pens.

Does Ozempic come in a 4 mg pen?

The 1 mg pen contains 4 mg of semaglutide in the cartridge. Some patients call it the 4 mg pen, but Novo Nordisk labels by dose delivered weekly.

What about the 8 mg pen?

The 2 mg pen contains 8 mg in the cartridge. Same naming logic as the 1 mg pen.

Can you get more than 4 doses out of a 1 mg pen?

The overfill is for priming, not for a fifth labeled dose. The dose counter stops at the labeled doses.

How many total milligrams are in each Ozempic pen?

2 mg in the starter pen, 4 mg in the 1 mg pen, 8 mg in the 2 mg pen.

Is dose count the same across Mounjaro and Zepbound?

No. Mounjaro and Zepbound use single-use auto-injectors. One dose per pen, no dialing.

What happens when an Ozempic pen runs out mid-injection?

The dose counter stops at the available volume. The patient should complete the remaining dose from a new pen.

Why do pen overfills exist?

For priming on first use and to account for residual cartridge volume. Not for extra therapeutic doses.

Can I refrigerate an in-use pen?

Yes. The pen can be refrigerated or kept at room temperature (up to 86 F / 30 C) for 56 days after first use.

Should I discard a pen if I dropped it?

Inspect for cracks, leaks, or damaged dose counter. If anything looks compromised, contact your pharmacist. Visible damage warrants discarding.

Does the pen contain other medications besides semaglutide?

Per Novo Nordisk's labeling, Ozempic pens contain semaglutide plus inactive ingredients (disodium phosphate dihydrate, propylene glycol, phenol, water). No other active pharmaceuticals.

Related guides

• How Many Clicks Are in a 1 mg Ozempic Pen? The Math Behind the Counter
• How Many Clicks Is 0.25 mg on a 1 mg Ozempic Pen? Off-Pen Math
• How Many Clicks on a 2 mg Ozempic Pen? The High-Dose Click Math
• How to Inject Ozempic Properly: The Full Step-by-Step
• How Many Clicks for 0.25 mg Ozempic? The First-Dose Math
• How Many Clicks for 0.5 mg Ozempic? The Second-Step Math
• Tool: dosage calculator

Sources

1. Novo Nordisk. Ozempic (semaglutide) injection prescribing information. Revised 2024.
2. Novo Nordisk. Ozempic Instructions for Use, 0.25/0.5 mg pen. 2023.
3. Novo Nordisk. Ozempic Instructions for Use, 1 mg pen. 2023.
4. Novo Nordisk. Ozempic Instructions for Use, 2 mg pen. 2023.
5. FDA. Ozempic 2 mg approval. March 2022.
6. FDA. Ozempic approval letter. December 2017.
7. Frias JP et al. SUSTAIN FORTE: Semaglutide 2.0 mg vs 1.0 mg. The Lancet Diabetes & Endocrinology. 2021.
8. Sorli C et al. SUSTAIN 1: Once-weekly semaglutide monotherapy. The Lancet Diabetes & Endocrinology. 2017.
9. ADA. Standards of Care in Diabetes 2026.
10. ISMP. Medication Safety Alert: Errors with Ozempic and Wegovy Pens. 2023.
11. Endocrine Society. Clinical Practice Guideline on Pharmacologic Management of Obesity. 2015 (updated 2024).
12. USP 797. Compounding Sterile Preparations. 2023.

Footer disclaimers

Platform Disclaimer. FormBlends connects patients with licensed prescribers and U.S. pharmacies. We do not manufacture, dispense, or instruct on pen mechanics outside the manufacturer's labeled use.

Compounded Medication Notice. Compounded semaglutide is not packaged in Novo Nordisk pens. Compounded preparations from 503A pharmacies typically ship as vials, with dose counts that depend on concentration and volume rather than a fixed pen mechanism.

Results Disclaimer. Pen capacity is a mechanical fact; therapeutic outcomes depend on adherence, prescriber-directed dose, and individual response.

Trademark Notice. Ozempic, Wegovy, Mounjaro, and Zepbound are registered trademarks of their respective manufacturers. FormBlends is not affiliated with Novo Nordisk or Eli Lilly.